Sponsor pipeline

Volastra Therapeutics, Inc. clinical trial pipeline

Get alerts when Volastra Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT05902988 A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer Advanced Solid Tumor Recruiting 2025-11-04
Phase 1
NCT06084416 A Study of Sovilnesib in Subjects With Ovarian Cancer High Grade Serous Adenocarcinoma of Ovary Recruiting 2026-10-13

Disease areas by active trials

Ovarian Cancer (2) · Breast Cancer (1) · Endometrial Cancer (1) · Head & Neck Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Sarcoma (1) · Triple-Negative Breast Cancer (1)

Get alerts when Volastra Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free